The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 07, 1984

Filed:

Jul. 23, 1981
Applicant:
Inventors:

Tobias O Yellin, Fremont, CA (US);

David J Gilman, Tytherington, GB;

Derrick F Jones, Tytherington, GB;

Keith Oldham, Cheadle, GB;

Assignees:

ICI Americas Inc., Wilmington, DE (US);

Imperial Chemical Industries PLC, London, GB;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D / ; C07D / ; A61K / ; A61K / ;
U.S. Cl.
CPC ...
424251 ; 544194 ; 544224 ; 544326 ; 544328 ; 544329 ; 546306 ; 548138 ; 548143 ; 548193 ; 548214 ; 548233 ; 548246 ; 548266 ; 548315 ; 548376 ; 564239 ;
Abstract

The invention relates to a guanidine derivative of the formula: ##STR1## in which W is a 2-6C alkylene chain optionally substituted by 1 or 2 1-4C alkyls; E is O, S, SO, SO.sub.2 or NR.sup.3 in which R.sup.3 is H or 1-6C alkyl; R.sup.1 is H or a straight chain 1-6C alkyl optionally substituted by 1 or 2 1-4C alkyls; or R.sup.1 and R.sup.3 are joined to form a morpholine, pyrrolidine, piperidine or piperazine ring; X, P, Y, Q and R.sup.2 are as defined in the specification, and the pharmaceutically-acceptable acid-addition salts thereof. Manufacturing process, pharmaceutical compositions and intermediates are also described. The compounds of the formula I are histamine H-2 antagonists.


Find Patent Forward Citations

Loading…